Journal article
Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy
Amy R Brooks-Kayal, Kevin G Bath, Anne T Berg, Aristea S Galanopoulou, Gregory L Holmes, Frances E Jensen, Andres M Kanner, Terence J O'Brien, Vicky H Whittemore, Melodie R Winawer, Manisha Patel, Helen E Scharfman
Epilepsia | WILEY | Published : 2013
DOI: 10.1111/epi.12298
Grants
Awarded by Office of the Director
Awarded by NATIONAL INSTITUTE OF MENTAL HEALTH
Awarded by NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Awarded by OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH
Funding Acknowledgements
Funding sources: R01NS38595 and grants from CURE, AES, the Epilepsy Foundation (EF) and the Colorado Center for Drug Discovery (ARB-K); NARSAD and EF (KGB); R37NS31146 and a grant from the Pediatric Epilepsy Foundation (ATB); R21NS078333 and R01NS020253 and grants from Autism Speaks, CURE, Heffer and Siegel Families Foundations (ASG); R01NS061991 and CURE (MRW); RO1NS039587, CURE, and Office of the Director grant R21NS072099 (MP); R01NS37562, R21MH090606, the Alzheimer's Association, and NYS Office of Mental Health (HES).